nach oben

Archives of Virology

Erschienen in:

15.09.2017 | Original Article

Efficacy and immunogenicity of recombinant swinepox virus expressing the truncated S protein of a novel isolate of porcine epidemic diarrhea virus

verfasst von: Xiaomin Yuan, Huixing Lin, Bin Li, Kongwang He, Hongjie Fan

Erschienen in: Archives of Virology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Porcine epidemic diarrhea virus (PEDV) causes significant loss to the swine industry. The emergence of novel PEDV strains in recent years has decreased the effectiveness of PEDV vaccines. We have developed a live recombinant vaccine, a swinepox virus vector that expresses a truncated S protein (rSPV-St) from a recent PEDV strain, SQ2014, and evaluated its immunogenicity and effectiveness in a swine model. Vaccination of swine with rSPV-St elicited a robust antibody response specific for the homologous PEDV SQ2014. Serum IgA titers in rSPV-St-vaccinated animals were significantly higher than in those immunized with inactivated vaccines. The effectiveness of antibodies induced by the rSPV-St vaccine in protection against PEDV was tested in a passive-transfer model in which piglets were challenged with the homologous virus SQ2014 and the heterologous strain CV777. When challenged with the homologous virus, sera from rSPV-St vaccination provided complete protection. However, sera from rSPV-St vaccination did not provide any protection against the heterologous virus challenge. Amino acid sequence differences in the S proteins of the two viruses were identified within neutralizing epitopes, which might have contributed to the divergent clinical results. Our data suggest that rSPV-St is potentially an effective vaccine against infection with emerging PEDV strains.

Debouck P, Pensaert M (1980) Experimental infection of pigs with a new porcine enteric coronavirus, CV 777. Am J Vet Res 41(2):219–223PubMed

Pijpers A, van Nieuwstadt AP, Terpstra C, Verheijden JH (1993) Porcine epidemic diarrhoea virus as a cause of persistent diarrhoea in a herd of breeding and finishing pigs. Vet Rec 132(6):129–131CrossRefPubMed

Pensaert MB, de Bouck P (1978) A new coronavirus-like particle associated with diarrhea in swine. Arch Virol 58(3):243–247CrossRefPubMed

Sun RQ, Cai RJ, Chen YQ, Liang PS, Chen DK, Song CX (2012) Outbreak of porcine epidemic diarrhea in suckling piglets, China. Emerg Infect Dis 18(1):161–163. doi:10.3201/eid1801.111259 CrossRefPubMedPubMedCentral

Crawford K, Lager KM, Kulshreshtha V, Miller LC, Faaberg KS (2016) Status of vaccines for porcine epidemic diarrhea virus in the United States and Canada. Virus Res 226:108–116. doi:10.1016/j.virusres.2016.08.005 CrossRefPubMed

Jinghui F, Yijing L (2005) Cloning and sequence analysis of the M gene of porcine epidemic diarrhea virus LJB/03. Virus Genes 30(1):69–73. doi:10.1007/s11262-004-4583-z CrossRefPubMed

Kusanagi K, Kuwahara H, Katoh T, Nunoya T, Ishikawa Y, Samejima T, Tajima M (1992) Isolation and serial propagation of porcine epidemic diarrhea virus in cell cultures and partial characterization of the isolate. J Vet Med Sci 54(2):313–318CrossRefPubMed

Song D, Park B (2012) Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines. Virus Genes 44(2):167–175. doi:10.1007/s11262-012-0713-1 CrossRefPubMed

Takahashi K, Okada K, Ohshima K (1983) An outbreak of swine diarrhea of a new-type associated with coronavirus-like particles in Japan. Nihon Juigaku Zasshi 45(6):829–832CrossRefPubMed

10.

Kocherhans R, Bridgen A, Ackermann M, Tobler K (2001) Completion of the porcine epidemic diarrhoea coronavirus (PEDV) genome sequence. Virus Genes 23(2):137–144CrossRefPubMed

11.

Duarte M, Tobler K, Bridgen A, Rasschaert D, Ackermann M, Laude H (1994) Sequence analysis of the porcine epidemic diarrhea virus genome between the nucleocapsid and spike protein genes reveals a polymorphic ORF. Virology 198(2):466–476. doi:10.1006/viro.1994.1058 CrossRefPubMed

12.

Jackwood MW, Hilt DA, Callison SA, Lee CW, Plaza H, Wade E (2001) Spike glycoprotein cleavage recognition site analysis of infectious bronchitis virus. Avian Dis 45(2):366–372CrossRefPubMed

13.

Lee DK, Park CK, Kim SH, Lee C (2010) Heterogeneity in spike protein genes of porcine epidemic diarrhea viruses isolated in Korea. Virus Res 149(2):175–182. doi:10.1016/j.virusres.2010.01.015 CrossRefPubMed

14.

Sun DB, Feng L, Shi HY, Chen JF, Liu SW, Chen HY, Wang YF (2007) Spike protein region (aa 636789) of porcine epidemic diarrhea virus is essential for induction of neutralizing antibodies. Acta Virol 51(3):149–156PubMed

15.

Chen Q, Li G, Stasko J, Thomas JT, Stensland WR, Pillatzki AE, Gauger PC, Schwartz KJ, Madson D, Yoon KJ, Stevenson GW, Burrough ER, Harmon KM, Main RG, Zhang J (2014) Isolation and characterization of porcine epidemic diarrhea viruses associated with the 2013 disease outbreak among swine in the United States. J Clin Microbiol 52(1):234–243. doi:10.1128/JCM.02820-13 CrossRefPubMedPubMedCentral

16.

Park SJ, Moon HJ, Yang JS, Lee CS, Song DS, Kang BK, Park BK (2007) Sequence analysis of the partial spike glycoprotein gene of porcine epidemic diarrhea viruses isolated in Korea. Virus Genes 35(2):321–332. doi:10.1007/s11262-007-0096-x CrossRefPubMed

17.

Lee S (2013) Lee C (2014) Outbreak-related porcine epidemic diarrhea virus strains similar to US strains, South Korea. Emerg Infect Dis 20(7):1223–1226. doi:10.3201/eid2007.140294 CrossRef

18.

Chang SH, Bae JL, Kang TJ, Kim J, Chung GH, Lim CW, Laude H, Yang MS, Jang YS (2002) Identification of the epitope region capable of inducing neutralizing antibodies against the porcine epidemic diarrhea virus. Mol Cells 14(2):295–299PubMed

19.

Vinicor F, Jack L Jr (2004) 25 years and counting: Centers for Disease Control and Prevention identifies opportunities and challenges for diabetes prevention and control. Ann Intern Med 140(11):943–944CrossRefPubMed

20.

Pastoret PP, Brochier B (1992) Development of a recombinant vaccinia-rabies vaccine for oral vaccination of foxes against rabies. Dev Biol Stand 79:105–111PubMed

21.

Taylor J, Weinberg R, Languet B, Desmettre P, Paoletti E (1988) Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine 6(6):497–503CrossRefPubMed

22.

Barcena J, Blasco R (1998) Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture. Virology 243(2):396–405. doi:10.1006/viro.1998.9053 CrossRefPubMed

23.

Hahn J, Park SH, Song JY, An SH, Ahn BY (2001) Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein. J Virol Methods 93(1–2):49–56CrossRefPubMed

24.

Huang D, Zhu H, Lin H, Xu J, Lu C (2012) First insights into the protective effects of a recombinant swinepox virus expressing truncated MRP of Streptococcus suis type 2 in mice. Berl Munch Tierarztl Wochenschr 125(3–4):144–152PubMed

25.

Xu J, Huang D, Liu S, Lin H, Zhu H, Liu B, Lu C (2012) Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs. Virus Res 167(2):188–195. doi:10.1016/j.virusres.2012.04.014 CrossRefPubMed

26.

Lin HX, Ma Z, Yang XQ, Fan HJ, Lu CP (2014) A novel vaccine against Porcine circovirus type 2 (PCV2) and Streptococcus equi ssp. zooepidemicus (SEZ) co-infection. Vet Microbiol 171(1–2):198–205. doi:10.1016/j.vetmic.2014.03.018 CrossRefPubMed

27.

Lin HX, Huang DY, Wang Y, Lu CP, Fan HJ (2011) A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein. Vaccine 29(40):7027–7034. doi:10.1016/j.vaccine.2011.07.074.S0264-410X(11)01123-6 CrossRefPubMed

28.

Soprana E, Panigada M, Knauf M, Radaelli A, Vigevani L, Palini A, Villa C, Malnati M, Cassina G, Kurth R, Norley S, Siccardi AG (2011) Joint production of prime/boost pairs of Fowlpox Virus and Modified Vaccinia Ankara recombinants carrying the same transgene. J Virol Methods 174(1–2):22–28. doi:10.1016/j.jviromet.2011.03.013 CrossRefPubMed

29.

Torres JM, Sanchez C, Sune C, Smerdou C, Prevec L, Graham F, Enjuanes L (1995) Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology 213(2):503–516. doi:10.1006/viro.1995.0023 CrossRefPubMed

30.

Yuan X, Lin H, Fan H (2015) Efficacy and immunogenicity of recombinant swinepox virus expressing the A epitope of the TGEV S protein. Vaccine 33(32):3900–3906. doi:10.1016/j.vaccine.2015.06.057 CrossRefPubMed

31.

Ishikawa K, Sekiguchi H, Ogino T, Suzuki S (1997) Direct and rapid detection of porcine epidemic diarrhea virus by RT-PCR. J Virol Methods 69(1–2):191–195CrossRefPubMed

32.

Sun M, Ma J, Wang Y, Wang M, Song W, Zhang W, Lu C, Yao H (2015) Genomic and epidemiological characteristics provide new insights into the phylogeographical and spatiotemporal spread of porcine epidemic diarrhea virus in Asia. J Clin Microbiol 53(5):1484–1492. doi:10.1128/JCM.02898-14 CrossRefPubMedPubMedCentral

33.

Tang M, Harp JA, Wesley RD (2002) Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2). Arch Virol 147(11):2125–2141. doi:10.1007/s00705-002-0870-y CrossRefPubMed

34.

Du Y, Li Y, He H, Qi J, Jiang W, Wang X, Tang B, Cao J, Jiang P (2008) Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine. J Virol Methods 149(1):144–152. doi:10.1016/j.jviromet.2007.12.018 CrossRefPubMed

35.

Chen F, Zhu Y, Wu M, Ku X, Ye S, Li Z, Guo X, He Q (2015) Comparative genomic analysis of classical and variant virulent parental/attenuated strains of porcine epidemic diarrhea virus. Viruses 7(10):5525–5538. doi:10.3390/v7102891.v7102891 CrossRefPubMedPubMedCentral

36.

Islam MT, Kubota T, Ujike M, Yahara Y, Taguchi F (2016) Phylogenetic and antigenic characterization of newly isolated porcine epidemic diarrhea viruses in Japan. Virus Res 222:113–119. doi:10.1016/j.virusres.2016.06.006 CrossRefPubMed

37.

Lin CM, Gao X, Oka T, Vlasova AN, Esseili MA, Wang Q, Saif LJ (2015) Antigenic relationships among porcine epidemic diarrhea virus and transmissible gastroenteritis virus strains. J Virol 89(6):3332–3342. doi:10.1128/JVI.03196-14 CrossRefPubMedPubMedCentral

38.

Chen H, Huang Q, Cui B, Li X, Guan Q (2008) Construction of recombinant fowlpox virus coexpressing HA from subtype H5 of avian influenza virus and chicken interleukin-18. Wei Sheng Wu Xue Bao 48(8):1025–1030PubMed

39.

Kyriakis CS, De Vleeschauwer A, Barbe F, Bublot M, Van Reeth K (2009) Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. Vaccine 27(16):2258–2264. doi:10.1016/j.vaccine.2009.02.006 CrossRefPubMed

Titel: Efficacy and immunogenicity of recombinant swinepox virus expressing the truncated S protein of a novel isolate of porcine epidemic diarrhea virus
verfasst von: Xiaomin Yuan
Huixing Lin
Bin Li
Kongwang He
Hongjie Fan
Publikationsdatum: 15.09.2017
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 12/2017
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-017-3548-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Efficacy and immunogenicity of recombinant swinepox virus expressing the truncated S protein of a novel isolate of porcine epidemic diarrhea virus

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2017

Complete genome sequence of a putative new caulimovirus which exists as endogenous pararetroviral sequences in Angelica dahurica

Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine

Cellular cholesterol is required for porcine nidovirus infection

Molecular characterization of very virulent infectious bursal disease virus strains circulating in Egypt from 2003 to 2014

Identification of a serotype-independent linear epitope of foot-and-mouth disease virus

miR-146a Inhibits dengue-virus-induced autophagy by targeting TRAF6

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin